Cox Manon M J
Protein Sciences Corporation, Meriden, Connecticut 06450, USA.
Yale J Biol Med. 2005 Oct;78(5):321-8.
Pandemic influenza has become a high priority item for all public health authorities. An influenza pandemic is believed to be imminent, and scientists agree that it will be a matter of when, where, and what will be the causative agent. Recently, most attention has been directed to human cases of avian influenza caused by a H5N1 avian influenza virus. An effective vaccine will be needed to substantially reduce the impact of an influenza pandemic. Current influenza vaccine manufacturing technology is not adequate to support vaccine production in the event of an avian influenza outbreak, and it has now become clear that new innovative production technology is required. Antiviral drugs, on the other hand, can play a very important role in slowing the disease spread but are in short supply and resistance has been a major issue. Here, we provide an update on the status of pandemic vaccine development and antiviral drugs. Finally, we conclude with some proposed areas of focus in pandemic vaccine preparedness.
大流行性流感已成为所有公共卫生当局的首要优先事项。人们认为流感大流行即将来临,科学家们一致认为问题在于何时、何地以及致病原是什么。最近,大部分注意力都集中在由H5N1禽流感病毒引起的人类禽流感病例上。需要一种有效的疫苗来大幅降低流感大流行的影响。目前的流感疫苗生产技术不足以在禽流感爆发时支持疫苗生产,现在已经很清楚需要新的创新生产技术。另一方面,抗病毒药物在减缓疾病传播方面可以发挥非常重要的作用,但供应短缺,耐药性一直是一个主要问题。在此,我们提供了大流行疫苗开发和抗病毒药物现状的最新情况。最后,我们总结了大流行疫苗准备工作中一些建议的重点领域。